Internal Medicine
A current review of COVID-19 for the cardiovascular specialist
1 Sep, 2020 | 06:06h | UTCA current review of COVID-19 for the cardiovascular specialist – American Heart Journal
AGA Guidelines on the gastrointestinal evaluation of iron deficiency anemia
1 Sep, 2020 | 06:02h | UTC
Perspective: COVID-19 vaccine trials should seek worthwhile efficacy
31 Aug, 2020 | 01:45h | UTCCOVID-19 vaccine trials should seek worthwhile efficacy – The Lancet
Commentary: Covid vaccine rush could make pandemic worse, say scientists – The Guardian
Commentary on Twitter
"Although efficacy far greater than 50% would be better, efficacy of about 50% would represent substantial progress"
Philip Krause et al for the @WHO Solidarity Vaccines Trial Expert Group on why #COVID19 vaccine trials should seek worthwhile efficacy https://t.co/2VWas8YU7L pic.twitter.com/RjbeZkeAE0
— The Lancet (@TheLancet) August 28, 2020
Study: Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2
31 Aug, 2020 | 01:47h | UTCRelated study: Salivary Detection of COVID-19 – Annals of Internal Medicine
Commentary on Twitter
Just published @NEJM
Strong support for saliva as an alternative to nasopharyngeal swab samples to detect #SARSCoV2
by @awyllie13 @YaleSPH and team @YaleMed https://t.co/waF5ODmiV8 pic.twitter.com/zw1D2JqW0y— Eric Topol (@EricTopol) August 28, 2020
A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU
31 Aug, 2020 | 01:44h | UTC
#ESCCongress – [Abstract Only] Randomized trial: Cardiovascular and renal outcomes with Empagliflozin in heart failure
31 Aug, 2020 | 01:38h | UTCCommentaries: EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF – TCTMD AND EMPEROR-Reduced meets primary endpoint in heart failure with reduced ejection fraction – European Society of Cardiology AND Empagliflozin Outcome Trial in Patients With Chronic Heart Failure and a Reduced Ejection Fraction – EMPEROR-Reduced – American College of Cardiology
Related study: Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine
Commentary on Twitter
Original Article: Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (EMPEROR-Reduced Trial) #ESCCongress
— NEJM (@NEJM) August 29, 2020
#ESCCongress – [Abstract Only] Randomized trial: Early rhythm-control therapy in patients with atrial fibrillation
31 Aug, 2020 | 01:39h | UTCEarly Rhythm-Control Therapy in Patients with Atrial Fibrillation – New England Journal of Medicine
Commentaries: Early rhythm control therapy improves outcomes in patients with atrial fibrillation – European Society of Cardiology AND Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4 – TCTMD AND Early Treatment of Atrial Fibrillation for Stroke Prevention Trial – EAST-AFNET 4 – American College of Cardiology AND EAST-AFNET 4: Is Early Rhythm-Control Therapy Associated With Lower Risk of CV Outcomes in Early AFIB Patients? – American College of Cardiology
Commentary on Twitter
Original Article: Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST–AFNET 4 Trial) #ESCCongress
— NEJM (@NEJM) August 29, 2020
#ESCCongress – [Abstract Only] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
31 Aug, 2020 | 01:36h | UTC
#ESCCongress – [Abstract Only] Randomized trial: Low-dose edoxaban in very elderly patients with atrial fibrillation
31 Aug, 2020 | 01:32h | UTCCommentaries: Edoxaban Low-Dose for Elder Care Atrial Fibrillation – ELDERCARE-AF – American College of Cardiology AND ELDERCARE-AF: Edoxaban Superior to Placebo in Preventing Stroke, Systemic Embolism in Elderly Japanese AFib Patients – American College of Cardiology
Commentary on Twitter
Elderly patients with AF who were not candidates for standard doses of oral anticoagulants because of a high risk of bleeding were assigned to receive 15 mg of edoxaban or placebo once daily. Edoxaban was superior to placebo in preventing stroke or systemic embolism. #ESCCongress
— NEJM (@NEJM) August 30, 2020
#ESCCongress – 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
31 Aug, 2020 | 01:20h | UTCNews Release: How to treat the most common heart attacks – European Society of Cardiology
Commentary: 2020 ESC NSTE-ACS Guidelines: Key Points – American College of Cardiology
Commentary on Twitter
ESC 2020 Guidelines for non-ST elevation acute coronary syndrome just released https://t.co/dKIngRO59K#ESCCongress #ESCGuidelines #cardiotwitter #MedTwitter pic.twitter.com/ihcnxcCzBw
— European Society of Cardiology (@escardio) August 29, 2020
#ESCCongress – 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation
31 Aug, 2020 | 01:18h | UTCNews Release: Heart rhythm disorders are best managed when patients are listened to – European Society of Cardiology
Commentary on Twitter
2020 ESC Guidelines for diagnosis & management of atrial fibrillation https://t.co/SSuQAr13TO#ESCCongress @escardio @ESC_Journals @AChoiHeart @purviparwani @DrMarthaGulati @ErinMichos @DrPascalMeier pic.twitter.com/5cLRSJbldp
— Open Heart (@Open_HeartBMJ) August 29, 2020
Updated Covid-19 Reviews: Hydroxychloroquine or Chloroquine / Masks / ACE Inhibitors or ARBs
28 Aug, 2020 | 08:54h | UTC- Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
- Update Alert 2: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings
- Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Meta-analysis: Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality
28 Aug, 2020 | 08:45h | UTC
Delirium and adverse outcomes in hospitalized patients with COVID‐19
28 Aug, 2020 | 08:46h | UTC
Prevalence, risk factors, and outcomes of hospitalized patients with COVID-19 presenting as acute pancreatitis
28 Aug, 2020 | 08:41h | UTCCommentary: Covid-19 can present with pancreatitis – MedicalResearch.com
Guideline synopsis: Ulcerative colitis in adults
28 Aug, 2020 | 08:38h | UTCUlcerative Colitis in Adults – JAMA
Podcast: Update on Ulcerative Colitis—2020
Original Guideline: AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis – Gastroenterology
Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
27 Aug, 2020 | 09:57h | UTCCommentaries: Obesity increases risk of complications from Covid-19, damages vaccine efficacy, study finds – CNN AND Obesity increases risk of Covid-19 death by 48%, study finds – The Guardian AND Obesity linked with higher risk for COVID-19 complications – University of North Carolina at Chapel Hill
Systematic Review: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection
27 Aug, 2020 | 09:55h | UTC
Commentary on Twitter (Thread – Click for more)
We have published our next Cochrane review of Covid-19 tests:
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection – Dinnes, J – 2020 | Cochrane Library https://t.co/EhD0onSgH0
— Jon Deeks FMedSci (@deeksj) August 26, 2020
Too many COVID-19 patients get unneeded ‘just in case’ antibiotics
27 Aug, 2020 | 10:00h | UTCToo many COVID-19 patients get unneeded ‘just in case’ antibiotics – University of Michigan
Viewpoint: The transformational effects of COVID-19 on medical education
27 Aug, 2020 | 09:52h | UTCThe Transformational Effects of COVID-19 on Medical Education – JAMA
Author Interview: The Transformational Effects of COVID-19 on Medical Education
[Abstract Only] Observational study: Therapeutic and prophylactic anticoagulation linked to lower in-hospital mortality in patients with Covid-19
27 Aug, 2020 | 09:51h | UTCCommentaries: Study provides more data on blood thinner efficacy for COVID-19 – The Mount Sinai Hospital AND Anticoagulants Associated With Better Survival, Lower Risk of Intubation in COVID-19 Patients
[Abstract Only] Meta-analysis: Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use
27 Aug, 2020 | 09:43h | UTCCommentary: Treating HIV And Tuberculosis Simultaneously Could Greatly Boost Patient Survival – Forbes
Commentary on Twitter:
NEW Research—Use of ART and more effective anti-tuberculosis drugs is associated with lower odds of death among HIV-positive patients with multidrug-resistant tuberculosis: finding from an individual patient data meta-analysis https://t.co/t3ZlxcaSQC pic.twitter.com/t8z9EWqyPU
— The Lancet (@TheLancet) August 11, 2020
COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
26 Aug, 2020 | 04:13h | UTCSee also: First Covid-19 reinfection documented in Hong Kong
Duration of SARS-CoV-2 infectivity: When is it safe to discontinue isolation?
26 Aug, 2020 | 04:14h | UTC
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
26 Aug, 2020 | 04:09h | UTCCommentary: COVID-19 symptoms can persist for months after hospital stay – CIDRAP